1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow HCV 796: new trials by email Literature Review of HCV 796 trials Research Report on HCV 796
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects Peg-Intron, REBETOL, HCV 796 - Hepatitis C | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 246 | 2006-10-01 | 2013-02-11 |
Hepatitis C (1)
Wyeth is now a wholly owned subsidiary of Pfizer (1)
Puerto Rico (1) · United States (1)